New Short Term Shared Lab Space Available from CEI LabForce in Phoenix

Thanks to generous support from the Flinn Foundation and the Arizona Department of Health Services, CEI LabForce is able to offer temporary shared lab space at their facility at 850 PBC in downtown Phoenix. Designed to support the needs of life science innovators at the proof-of-concept stage, the lab provides access to cutting-edge equipment and resources, enabling researchers and startups to accelerate their projects without the burden of substantial upfront investments.Continue reading

Exploring Pathways to Bioscience and Healthcare Careers during AZBW 2024

Attention Teachers! Are you looking for free, engaging, on-demand resources to inspire your students with the possibilities in Arizona’s Bioscience and Healthcare industries? Thanks to the Exploring Pathways to Bioscience and Healthcare Careers grant, and support by the Flinn Foundation and the Office of the Maricopa County School Superintendent we have new resources for you and your students to enjoy during and after Arizona Bioscience Week.Continue reading

Flambeau Medical is Growing in Phoenix

Flambeau Medical, a full-service, contract manufacturing organization serving the medical device and life science industries is growing in Phoenix. The company provides a full suite of development and manufacturing capabilities in FDA registered and ISO-13485:2016 certified manufacturing operations.Continue reading

Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful completion of its WAVE pre-clinical trial. The Accelerate WAVE system is designed to deliver rapid antimicrobial susceptibility testing (“AST”) directly from positive blood culture (“PBC”) bottles and bacterial isolated colonies (“Isolates”) to report accurate results within 4.5 hours, on average.Continue reading

Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine

LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ – Anivive Lifesciences Inc, a One Health technology company today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded Anivive a new contract (#75N93024C00009) worth up to $33M to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.Continue reading